 |
PDBsum entry 3zh8
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
A novel small molecule apkc inhibitor
|
|
Structure:
|
 |
Protein kinasE C iota type. Chain: a, b, c. Fragment: kinase domain, residues 248-596. Synonym: pkc iota, atypical protein kinasE C-lambda/iota, prkc- lambda/iota, apkc-lambda/iota, npkc-iota. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: high five.
|
|
Resolution:
|
 |
|
2.74Å
|
R-factor:
|
0.213
|
R-free:
|
0.257
|
|
|
Authors:
|
 |
S.Kjaer,A.G.Purkiss,B.Kostelecky,P.P.Knowles,E.Soriano,J.Murray-Rust, N.Q.Mcdonald
|
|
Key ref:
|
 |
S.Kjær
et al.
(2013).
Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.
Biochem J,
451,
329-342.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Dec-12
|
Release date:
|
27-Feb-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P41743
(KPCI_HUMAN) -
Protein kinase C iota type from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
596 a.a.
320 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.13
- protein kinase C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochem J
451:329-342
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.
|
|
S.Kjær,
M.Linch,
A.Purkiss,
B.Kostelecky,
P.P.Knowles,
C.Rosse,
P.Riou,
C.Soudy,
S.Kaye,
B.Patel,
E.Soriano,
J.Murray-Rust,
C.Barton,
C.Dillon,
J.Roffey,
P.J.Parker,
N.Q.McDonald.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The aPKC [atypical PKC (protein kinase C)] isoforms ι and ζ play crucial roles
in the formation and maintenance of cell polarity and represent attractive
anti-oncogenic drug targets in Ras-dependent tumours. To date, few
isoform-specific chemical biology tools are available to inhibit aPKC catalytic
activity. In the present paper, we describe the identification and functional
characterization of potent and selective thieno[2,3-d]pyrimidine-based chemical
inhibitors of aPKCs. A crystal structure of human PKCι kinase domain bound to a
representative compound, CRT0066854, reveals the basis for potent and selective
chemical inhibition. Furthermore, CRT0066854 displaces a crucial Asn-Phe-Asp
motif that is part of the adenosine-binding pocket and engages an acidic patch
used by arginine-rich PKC substrates. We show that CRT0066854 inhibits the LLGL2
(lethal giant larvae 2) phosphorylation in cell lines and exhibits phenotypic
effects in a range of cell-based assays. We conclude that this compound can be
used as a chemical tool to modulate aPKC activity in vitro and in vivo and may
guide the search for further aPKC-selective inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |